Homeostasis

Kanazawa University research: Researchers define a nanopipette fabrication protocol for high resolution cell imaging

Retrieved on: 
Tuesday, August 22, 2023

KANAZAWA, Japan, Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.

Key Points: 
  • KANAZAWA, Japan, Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.
  • Now researchers led by Yasufumi Takahashi at Kanazawa University's Nano LSI and Nagoya University have devised a protocol for reproducibly fabricating nanopipettes with the preferred geometry for high quality imaging.
  • Scanning ion conductance microscopy (SICM) uses a nanopipette to control the nanopipette-samples distance using an ion current as feedback signal.
  • Nanopipette Fabrication Guidelines for SICM Nanoscale Imaging, Analytical Chemistry August 20, 2023.

Kanazawa University research: Researchers define a nanopipette fabrication protocol for high resolution cell imaging

Retrieved on: 
Tuesday, August 22, 2023

KANAZAWA, Japan , Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.

Key Points: 
  • KANAZAWA, Japan , Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.
  • Now researchers led by Yasufumi Takahashi at Kanazawa University's Nano LSI and Nagoya University have devised a protocol for reproducibly fabricating nanopipettes with the preferred geometry for high quality imaging.
  • Scanning ion conductance microscopy (SICM) uses a nanopipette to control the nanopipette-samples distance using an ion current as feedback signal.
  • Nanopipette Fabrication Guidelines for SICM Nanoscale Imaging, Analytical Chemistry August 20, 2023.

Specialdocs Launches 10 Personalized Care Practices Nationwide Since the Start of 2023

Retrieved on: 
Tuesday, July 18, 2023

“Like concierge medicine itself, which allows for deeply personalized doctor-patient relationships, our model is grounded in a trusted and enduring partnership.

Key Points: 
  • “Like concierge medicine itself, which allows for deeply personalized doctor-patient relationships, our model is grounded in a trusted and enduring partnership.
  • It’s like night and day in terms of how I can care for and really know my patients.
  • We signed up for her personalized medical care as soon as she made it available.
  • I told her then ‘I’d been hoping for years you would start a practice like this.

BioVie Issues Letter to Shareholders

Retrieved on: 
Tuesday, July 18, 2023

Over 3,000 significant correlations were found linking reductions in DNA methylation of various CpGs and cognitive, biomarker and neuroimaging endpoints.

Key Points: 
  • Over 3,000 significant correlations were found linking reductions in DNA methylation of various CpGs and cognitive, biomarker and neuroimaging endpoints.
  • I have prepared this letter to shareholders to provide an update that synthesizes all the information that we have released and presented at recent medical conferences.
  • NE3107 reduced CSF phospho-tau levels by -1.66 pg/mL (p=0.0343) and the ratio of p-tau to amyloid beta 42 (Aβ42) by -0.0024 (p=0.0401).
  • P-tau and Aβ are traditional biomarkers of AD progression and have been the focus for AD researchers for decades.

ExThera Medical Announces FDA Approval of IDE Application for Use of the OncoBindTM Extracorporeal Procedure to Remove Circulating Tumor Cells in Patients with Pancreatic Cancer

Retrieved on: 
Thursday, July 13, 2023

CTCs are tumor cells that are cast off from a primary tumor and enter the bloodstream which cause metastatic cancer.

Key Points: 
  • CTCs are tumor cells that are cast off from a primary tumor and enter the bloodstream which cause metastatic cancer.
  • “This is an important milestone for ExThera Medical and we are thrilled to be advancing the OncoBindTM procedure into a novel category of clinical development,” said Sanja ILIC, M.D., M.S., RAC & Chief Regulatory Officer for ExThera.
  • We are pleased to begin an important new clinical trial, and ecstatic that FDA has approved our recent IDE application.
  • ExThera Medical is dedicated to transparency, safety, and efficacy of all of its products, developed under FDA oversight.

Ocean Biomedical’s (NASDAQ: OCEA) mRNA-based Vaccine Candidate Generates Over 90% Killing of Malaria Parasites in Non-human Primates, Demonstrating Broad Potential for Ocean’s Program to Address Global and Emerging U.S. Malaria Challenges

Retrieved on: 
Tuesday, July 11, 2023

Providence, RI, July 11, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research scientists, announced today that it is focusing its multi-pronged malaria program to address the chronic malaria crisis in sub-Saharan Africa while recognizing newly emerging global malaria challenges.

Key Points: 
  • Based on discoveries by Scientific Co-founder, Jonathan Kurtis, MD, PhD, Ocean Biomedical is working on a multivalent mRNA-based malaria vaccine with potential to target several stages in the malaria cycle.
  • Additionally, the company has discovered a new therapeutic approach with the potential to launch a whole new class of anti-malarials.
  • Multiple U.S. and global patents are held by Ocean Biomedical for both the vaccine and therapeutic approaches.
  • Ocean Biomedical’s novel malaria vaccine program is based on groundbreaking discoveries by Dr. Kurtis that have revealed new insights into how malaria parasites maintain homeostasis in their hosts.

Aging is complicated – a biologist explains why no two people or cells age the same way, and what this means for anti-aging interventions

Retrieved on: 
Thursday, July 6, 2023

And you likely have seen the opposite – someone whose body and mind seem much more ravaged by time than others.

Key Points: 
  • And you likely have seen the opposite – someone whose body and mind seem much more ravaged by time than others.
  • Aging research doesn’t tend to be about finding the one cure that fixes all that may ail you in old age.

What is aging?

    • This process is both intrinsic, when your own body causes new problems, and extrinsic, when environmental insults damage your tissues.
    • This includes metabolizing nutrients, getting rid of waste, exchanging signals with other cells and adapting to stress.
    • The trouble is that every single process and component in each of your cells can be interrupted or damaged.

Repairing DNA and recycling proteins

    • One of the cell’s chief jobs is to maintain its DNA – the instruction manual a cell’s machinery reads to produce specific proteins.
    • DNA maintenance involves protecting against, and accurately repairing, damage to genetic material and the molecules binding to it.
    • If the protein is damaged, the cell uses mechanisms involving special proteins that either attempt to fix the broken protein or send it off for recycling.

Aging disrupts a delicate biological network

    • The cross-talk between the components inside cells, cells as a whole, organs and the environment is a complex and ever-changing network of information.
    • For an organ to work well, the majority of the cells that make it up need to function well.
    • Aging can lead to dysfunction at any of these levels, from the sub-cellular to the organismal.

Anti-aging interventions

    • In fact, this is how the most successful anti-aging interventions work.
    • There is no silver bullet to stop aging, but certain interventions do seem to slow aging in the laboratory.
    • One of the best studied interventions is caloric restriction, which involves reducing the amount of calories an animal would normally eat without depriving them of necessary nutrients.
    • However, researching interventions that target multiple important cellular processes simultaneously could help improve and maintain health for a greater portion of life.

Cymbiotika's Inflammatory Health Wins 2023 Mindful Award for Bone and Joint Health Product of the Year

Retrieved on: 
Tuesday, June 27, 2023

SAN DIEGO, June 27, 2023 /PRNewswire/ -- Cymbiotika, a leading health and wellness company committed to creating clean, premium nutritional supplements, is thrilled to announce that its product, Inflammatory Health, has been honored as the winner of the prestigious 2023 Mindful Award for Bone and Joint Health Product of the Year.

Key Points: 
  • SAN DIEGO, June 27, 2023 /PRNewswire/ -- Cymbiotika, a leading health and wellness company committed to creating clean, premium nutritional supplements, is thrilled to announce that its product, Inflammatory Health, has been honored as the winner of the prestigious 2023 Mindful Award for Bone and Joint Health Product of the Year.
  • The award recognizes Cymbiotika's ability to create revolutionary formulas that support bone and joint health and promote overall well-being.
  • Inflammatory Health, launched by Cymbiotika on January 24th, 2022, has experienced remarkable success since its introduction to the market.
  • "We are honored to receive the 2023 Mindful Award for Bone and Joint Health Product of the Year for our Inflammatory Health supplement," said Shahab Elmi, CEO and Co-Founder of Cymbiotika.

Internet of microbiota: could synthetic probiotics help prevent our natural bacteria from going astray?

Retrieved on: 
Tuesday, June 20, 2023

Indeed, the human microbiota – the natural bacteria inside the human body – use “quorum sensing” molecules to organise themselves and communicate with their human host.

Key Points: 
  • Indeed, the human microbiota – the natural bacteria inside the human body – use “quorum sensing” molecules to organise themselves and communicate with their human host.
  • Recent research has shown that artificial bacteria, also called “synthetic probiotics”, could offer a promising new approach to treating gut-brain axis disorders.
  • These artificial bacteria would use molecular communication, as it occurs naturally in living organisms, but here as a bio-inspired communication paradigm that uses molecules to transfer information.

What are artificial bacteria?

    • The active use of artificial bacteria in the treatment of gut-brain axis-related disorders is projected to make significant breakthroughs.
    • For example, by developing artificial bacteria to produce antimicrobial peptides, we can target and kill harmful bacteria with greater precision, avoiding the development of antibiotic resistance.
    • The development of intestinal biosensors and artificial bacteria to detect disease-related biomarkers enables using them as diagnostic tools.

How to develop artificial bacteria?

    • In the context of molecular communication, artificial bacteria refers to the development of engineered bacteria that can communicate with each other and human cells at the molecular level.
    • This envisioned organism is nothing but a network of systems transmitting and receiving, or, in engineering speak, “transceiving” molecules at the microscale or the nanoscale.
    • This bacteria-based transceiver can send and receive molecular signals inside the human body to further sense and control biological processes in real time.
    • As stated before, envisioned artificial bacteria is a perfect candidate for biomedical applications of nano-communication networks such as diagnosis and treatment of diseases, health monitoring, drug delivery, and bio-hybrid implants.

Sequantrix Launches Operations

Retrieved on: 
Tuesday, June 20, 2023

Sequantrix is Home Biosciences’ second venture.

Key Points: 
  • Sequantrix is Home Biosciences’ second venture.
  • Sequantrix harnesses the latest advancements in computational and organoid technologies and research to decode fibrosis and unlock a new wave of novel therapies with an initial focus on kidney and bone marrow.
  • Sequantrix has four novel validated therapeutic targets and will be starting drug development activities in the coming months.
  • We are confident that Sequantrix can impact novel fibrotic disease drug discovery and development for the benefit of patients, particularly also for those suffering from bone marrow fibrosis” adds Dr. Rebekka Schneider.